In a recent transaction, Thomas L. Beaudoin, serving as a director of Cerence Inc . (NASDAQ:CRNC), sold 5,000 shares of the company's common stock. The sale, executed on October 1, 2024, was conducted at a price of $3.13 per share, totaling $15,650.
This sale was made in accordance with a Rule 10b5-1 trading plan, which Beaudoin had previously adopted on December 21, 2023. Such trading plans allow company insiders to sell a predetermined number of shares at a predetermined time to avoid accusations of trading on nonpublic information.
Following the transaction, Beaudoin continues to hold a substantial position in the company, with 217,457 shares of Cerence Inc. remaining in his possession. The details of the transaction were disclosed in a Form 4 filing with the Securities and Exchange Commission.
Cerence Inc. specializes in creating software for the automotive industry and has been a key player in the field of prepackaged software services. The transaction by Beaudoin is of interest to investors who closely monitor insider activities as potential indicators of a company's financial health and future performance.
Investors and analysts often view insider sales and purchases as a signal of their confidence in the company's prospects, making such disclosures an essential piece of information for the investment community.
In other recent news, Cerence Inc. reported revenues of $70.5 million in its fiscal year 2024 third-quarter earnings call, a 14% increase year-over-year. Despite a significant goodwill impairment charge of approximately $357 million affecting GAAP profitability, the company's non-GAAP profitability exceeded its own projections. Adjusted EBITDA reached $12.5 million, with an operational cash flow of $12.9 million. TD Cowen adjusted its outlook on Cerence by reducing its price target from $12.00 to $10.00, while maintaining a Buy rating. This change reflects a strategic shift within Cerence as the company undertakes a significant restructuring program, expected to save between $35 million and $40 million. Cerence's management team is now anticipated to shift its attention to addressing the company's financial obligations, specifically the $87 million in 3% debt that is due in June 2025. In terms of future outlook, Cerence expects flat to a slight decrease in revenue for fiscal year 2025, while expecting improved gross margins. The company is also committed to advancing its generative AI and large language model solutions, alongside developing a next-generation AI computing platform. These are the recent developments at Cerence.
InvestingPro Insights
To provide additional context to Thomas L. Beaudoin's recent stock sale, let's examine some key financial metrics and insights from InvestingPro for Cerence Inc. (NASDAQ:CRNC).
According to InvestingPro data, Cerence's market capitalization stands at $109.11 million, reflecting its current position in the prepackaged software services sector. The company's revenue for the last twelve months as of Q3 2024 was $357.46 million, with a notable revenue growth of 31.49% over the same period.
Despite this growth, InvestingPro Tips highlight that Cerence has not been profitable over the last twelve months. This aligns with the reported basic and diluted EPS (Continuing Operations) of -$14.04. However, an encouraging InvestingPro Tip suggests that analysts predict the company will be profitable this year, which could explain why insiders like Beaudoin maintain significant holdings despite selling some shares.
The stock's performance has been challenging, with InvestingPro data showing a 6-month price total return of -81.17% and a 1-year return of -85.3%. This context adds weight to another InvestingPro Tip indicating that the stock price movements are quite volatile, which investors should consider when interpreting insider transactions like Beaudoin's sale.
It's worth noting that Cerence's price-to-book ratio stands at 0.72, suggesting the stock might be undervalued relative to its book value. This could be of interest to value investors looking at the company's long-term potential despite recent stock performance.
For those seeking a more comprehensive analysis, InvestingPro offers additional tips and metrics that could provide further insights into Cerence's financial health and market position. There are 8 more InvestingPro Tips available for CRNC, which could be valuable for investors conducting due diligence on the company in light of recent insider activity.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.